{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:07:06Z","timestamp":1779246426834,"version":"3.51.4"},"reference-count":215,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["GZC20251955"],"award-info":[{"award-number":["GZC20251955"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.biopha.2026.119358","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T13:07:36Z","timestamp":1776172056000},"page":"119358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanistic insights and clinical implications of the S100 protein family in breast cancer"],"prefix":"10.1016","volume":"198","author":[{"given":"Shu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3117-9173","authenticated-orcid":false,"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tips.2024.02.002","article-title":"Translational adaptation in breast cancer metastasis and emerging therapeutic opportunities","volume":"45","author":"Chen","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2026.119358_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103835","article-title":"Current and future burden of breast cancer in Asia: A GLOBOCAN data analysis for 2022 and 2050","volume":"79","author":"Fu","year":"2025","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10549-020-05861-6","article-title":"Characteristics and prognosis of 17 special histologic subtypes of invasive breast cancers according to World Health Organization classification: comparative analysis to invasive carcinoma of no special type","volume":"184","author":"Kim","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.biopha.2026.119358_bib4","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2147\/BCTT.S432526","article-title":"Breast cancer: an overview of current therapeutic strategies, challenge, and perspectives","author":"Wang","year":"2023","journal-title":"Breast Cancer Targets Therapy"},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000512277","article-title":"The role of calcium signaling in regulation of epithelial-mesenchymal transition","volume":"211","author":"Adiga","year":"2022","journal-title":"Cells Tissues Organs"},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10555-024-10172-z","article-title":"Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance","volume":"43","author":"Bhat","year":"2024","journal-title":"Cancer Metastas-.-. Rev."},{"key":"10.1016\/j.biopha.2026.119358_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-1-4939-9030-6_11","article-title":"Ca2+-binding proteins of the EF-hand superfamily: diagnostic and prognostic biomarkers and novel therapeutic targets","author":"Heizmann","year":"2019","journal-title":"Calcium-Bind. Proteins EF-hand superfamily Basics Med. Appl."},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1825","article-title":"Fates and functions of RNA-binding proteins under stress","volume":"15","author":"Goswami","year":"2024","journal-title":"Wiley Interdisciplinary Reviews RNA"},{"issue":"8","key":"10.1016\/j.biopha.2026.119358_bib9","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1007\/s12015-022-10403-2","article-title":"S100A6 as a constituent and potential marker of adult and cancer stem cells","volume":"18","author":"Le\u015bniak","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2026.119358_bib10","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.7150\/jca.73365","article-title":"The role of the S100 protein family in glioma","volume":"13","author":"Wang","year":"2022","journal-title":"J. Cancer"},{"issue":"20","key":"10.1016\/j.biopha.2026.119358_bib11","doi-asserted-by":"crossref","first-page":"12427","DOI":"10.1074\/jbc.273.20.12427","article-title":"High level expression and dimer characterization of the S100 EF-hand proteins, migration inhibitory factor-related proteins 8 and 14","volume":"273","author":"Hunter","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119358_bib12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-4939-9030-6_18","article-title":"S100 Proteins in the Innate Immune Response to Pathogens","volume":"1929","author":"Kozlyuk","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119358_bib13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jmb.2007.04.065","article-title":"The crystal structure of the human (S100A8\/S100A9)2 heterotetramer, calprotectin, illustrates how conformational changes of interacting alpha-helices can determine specific association of two EF-hand proteins","volume":"370","author":"Korndorfer","year":"2007","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib14","first-page":"e67","article-title":"S100 protein in breast tumor","volume":"51","author":"Li","year":"2014","journal-title":"Indian J. Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2026.119358_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082037","article-title":"Friend or Foe: S100 Proteins in Cancer","volume":"12","author":"Allgower","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jmb.2006.03.066","article-title":"Structural basis for diversity of the EF-hand calcium-binding proteins","volume":"359","author":"Grabarek","year":"2006","journal-title":"J. Mol. Biol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119358_bib17","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1002\/pro.3233","article-title":"Structural and functional diversity of EF-hand proteins: Evolutionary perspectives","volume":"26","author":"Kawasaki","year":"2017","journal-title":"Protein Sci."},{"issue":"4172","key":"10.1016\/j.biopha.2026.119358_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1126\/science.1111094","article-title":"Troponin and parvalbumin calcium binding regions predicted in myosin light chain and T4 lysozyme","volume":"187","author":"Tufty","year":"1975","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.biopha.2026.119358_bib19","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.1111\/j.1742-4658.2008.06654.x","article-title":"S100-annexin complexes--structural insights","volume":"275","author":"Rintala-Dempsey","year":"2008","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejso.2007.04.009","article-title":"A review of the S100 proteins in cancer","volume":"34","author":"Salama","year":"2008","journal-title":"Eur. J. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119358_bib21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0969-2126(03)00126-6","article-title":"Unmasking the annexin I interaction from the structure of Apo-S100A11","volume":"11","author":"Dempsey","year":"2003","journal-title":"Structure"},{"issue":"33","key":"10.1016\/j.biopha.2026.119358_bib22","doi-asserted-by":"crossref","first-page":"11460","DOI":"10.1021\/jacs.7b04380","article-title":"Calcium-mediated control of s100 proteins: allosteric communication via an agitator\/signal blocking mechanism","volume":"139","author":"Xiao","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00775-010-0721-3","article-title":"Structural characterization of human S100A16, a low-affinity calcium binder","volume":"16","author":"Babini","year":"2011","journal-title":"J. Biol. Inorg. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00775-012-0963-3","article-title":"Solution structure and dynamics of human S100A14","volume":"18","author":"Bertini","year":"2013","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.biopha.2026.119358_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/bs.acc.2020.02.006","article-title":"S100 family proteins in inflammation and beyond","volume":"98","author":"Sreejit","year":"2020","journal-title":"Adv. Clin. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1006\/bbrc.1996.0496","article-title":"Novel specific chemtactic receptor for S100L protein on guinea pig eosinophils","volume":"220","author":"Komada","year":"1996","journal-title":"Biochem Biophys. Res Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1523-1747.ep12294284","article-title":"Psoriasin: a novel chemotactic protein","volume":"107","author":"Jinquan","year":"1996","journal-title":"J. Invest Dermatol."},{"issue":"7","key":"10.1016\/j.biopha.2026.119358_bib28","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.4049\/jimmunol.150.7.2981","article-title":"Identification of a chemotactic domain of the pro-inflammatory S100 protein CP-10","volume":"150","author":"Lackmann","year":"1993","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/(SICI)1097-4652(199602)166:2<427::AID-JCP21>3.0.CO;2-6","article-title":"S100 protein CP-10 stimulates myeloid cell chemotaxis without activation","volume":"166","author":"Cornish","year":"1996","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119358_bib30","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1177\/00220345990780060901","article-title":"Migration inhibitory factor related protein-8 (MRP-8) is an autocrine chemotactic factor for periodontal ligament cells","volume":"78","author":"Nishimura","year":"1999","journal-title":"J. Dent. Res."},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1189\/jlb.1008647","article-title":"The endogenous Toll-like receptor 4 agonist S100A8\/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer","volume":"86","author":"Ehrchen","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119358_bib32","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.4049\/jimmunol.170.6.3233","article-title":"Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8\/A9 induce neutrophil chemotaxis and adhesion","volume":"170","author":"Ryckman","year":"2003","journal-title":"J. Immunol."},{"issue":"19","key":"10.1016\/j.biopha.2026.119358_bib33","doi-asserted-by":"crossref","first-page":"13035","DOI":"10.1074\/jbc.M710388200","article-title":"Mast cell and monocyte recruitment by S100A12 and its hinge domain","volume":"283","author":"Yan","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib34","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/jid.2008.268","article-title":"The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption","volume":"129","author":"Glaser","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119358_bib35","first-page":"1954","article-title":"Psoriasin interacts with Jab1 and influences breast cancer progression","volume":"63","author":"Emberley","year":"2003","journal-title":"Cancer Res"},{"issue":"51","key":"10.1016\/j.biopha.2026.119358_bib36","doi-asserted-by":"crossref","first-page":"40096","DOI":"10.1074\/jbc.M006993200","article-title":"Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation","volume":"275","author":"Huttunen","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2026.119358_bib37","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/jlb.62.6.852","article-title":"Epithelioid cells from foreign-body granuloma selectively express the calcium-binding protein MRP-14, a novel down-regulatory molecule of macrophage activation","volume":"62","author":"Aguiar-Passeti","year":"1997","journal-title":"J. Leukoc. Biol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119358_bib38","first-page":"447","article-title":"A Protein Complex Expressed during Terminal Differentiation of Monomyelocytic Cells Is an Inhibitor of Cell-Growth","volume":"1","author":"Murao","year":"1990","journal-title":"Cell Growth & Differ."},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/jlb.58.3.307","article-title":"Purification and characterization of the cytotoxic factor in rat peritoneal exudate cells: its identification as the calcium binding protein complex, calprotectin","volume":"58","author":"Yui","year":"1995","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0167-4889(99)00058-0","article-title":"Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type","volume":"1450","author":"Donato","year":"1999","journal-title":"Biochim Biophys. Acta"},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib41","first-page":"363","article-title":"Innate immune cells and C-reactive protein in acute first-episode psychosis and schizophrenia: relationship to psychopathology and treatment","volume":"46","author":"Steiner","year":"2020","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.biopha.2026.119358_bib42","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-3083.1994.tb03523.x","article-title":"Effects of Human Calprotectin (L1) on in-Vitro Immunoglobulin-Synthesis","volume":"40","author":"Brun","year":"1994","journal-title":"Scand. J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/156652413804486214","article-title":"Functions of S100 proteins","volume":"13","author":"Donato","year":"2013","journal-title":"Curr. Mol. Med"},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/1096-9861(20000821)424:2<269::AID-CNE6>3.0.CO;2-M","article-title":"Metastasis-associated mts1 (S100A4) protein in the developing and adult central nervous system","volume":"424","author":"Aberg","year":"2000","journal-title":"J. Comp. Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib45","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0006-8993(96)01463-1","article-title":"S-100beta stimulates neurite outgrowth in the rat sciatic nerve grafted with acellular muscle transplants","volume":"753","author":"Haglid","year":"1997","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib46","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/glia.20924","article-title":"Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease","volume":"58","author":"Mori","year":"2010","journal-title":"Glia"},{"issue":"7","key":"10.1016\/j.biopha.2026.119358_bib47","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1357-2725(01)00046-2","article-title":"S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles","volume":"33","author":"Donato","year":"2001","journal-title":"Int J. Biochem Cell Biol."},{"issue":"48","key":"10.1016\/j.biopha.2026.119358_bib48","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/bi981713l","article-title":"The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation","volume":"37","author":"Kassam","year":"1998","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib49","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jmb.2009.06.004","article-title":"The Crystal Structures of Human S100A12 in Apo Form and in Complex with Zinc: New Insights into S100A12 Oligomerisation","volume":"391","author":"Moroz","year":"2009","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ni1142","article-title":"Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection","volume":"6","author":"Glaser","year":"2005","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1574-695X.2000.tb01501.x","article-title":"Calprotectin (MRP8\/14 protein complex) release during mycobacterial infection in vitro and in vivo","volume":"29","author":"Pechkovsky","year":"2000","journal-title":"Fems Immunol. Med. Microbiol."},{"issue":"25","key":"10.1016\/j.biopha.2026.119358_bib52","doi-asserted-by":"crossref","first-page":"22699","DOI":"10.1074\/jbc.M010231200","article-title":"Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1\/S100A4 protein: functional consequences of their interaction","volume":"276","author":"Grigorian","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib53","doi-asserted-by":"crossref","first-page":"593","DOI":"10.18388\/abp.2012_2097","article-title":"S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13","volume":"59","author":"Wang","year":"2012","journal-title":"Acta Biochim Pol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119358_bib54","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1023\/B:CLIN.0000006819.21361.03","article-title":"S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells","volume":"20","author":"Mathisen","year":"2003","journal-title":"Clin. Exp. Metastas-.-."},{"issue":"8","key":"10.1016\/j.biopha.2026.119358_bib55","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1158\/1541-7786.MCR-05-0266","article-title":"Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma","volume":"4","author":"Tsai","year":"2006","journal-title":"Mol. Cancer Res"},{"issue":"24","key":"10.1016\/j.biopha.2026.119358_bib56","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0021-9258(18)67402-2","article-title":"Identification of a Molecular Target for the Calcium-Modulated Protein-S100 - Fructose-1,6-Bisphosphate Aldolase","volume":"261","author":"Zimmer","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib57","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0143-4160(96)90033-0","article-title":"Identification of an S100A1\/S100B target protein: phosphoglucomutase","volume":"20","author":"Landar","year":"1996","journal-title":"Cell Calcium"},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib58","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0143-4160(93)90053-9","article-title":"Identification of an S100 target protein: glycogen phosphorylase","volume":"14","author":"Zimmer","year":"1993","journal-title":"Cell Calcium"},{"issue":"14","key":"10.1016\/j.biopha.2026.119358_bib59","doi-asserted-by":"crossref","first-page":"8356","DOI":"10.1016\/S0021-9258(18)83189-1","article-title":"A Protein Containing the Cystic-Fibrosis Antigen Is an Inhibitor of Protein-Kinases","volume":"264","author":"Murao","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"27","key":"10.1016\/j.biopha.2026.119358_bib60","doi-asserted-by":"crossref","first-page":"17145","DOI":"10.1074\/jbc.272.27.17145","article-title":"P11, a unique member of the S100 family of calcium-binding proteins, interacts with and inhibits the activity of the 85-kDa cytosolic phospholipase A2","volume":"272","author":"Wu","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0014-5793(89)81127-5","article-title":"S-100a0 protein stimulates Ca2+-induced Ca2+ release from isolated sarcoplasmic reticulum vesicles","volume":"255","author":"Fano","year":"1989","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.biopha.2026.119358_bib62","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF01737993","article-title":"S-100ab increases Ca2+ release in purified sarcoplasmic reticulum vesicles of frog skeletal muscle","volume":"13","author":"Marsili","year":"1992","journal-title":"J. Muscle Res Cell Motil."},{"issue":"10","key":"10.1016\/j.biopha.2026.119358_bib63","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1158\/0008-5472.CAN-05-3087","article-title":"The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA","volume":"66","author":"Li","year":"2006","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib64","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0306-4522(00)00238-4","article-title":"Effects of S100A1 and S100B on microtubule stability. An in vitro study using triton-cytoskeletons from astrocyte and myoblast cell lines","volume":"99","author":"Sorci","year":"2000","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.biopha.2026.119358_bib65","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ncb1206-1321","article-title":"S100 chemokines mediate bookmarking of premetastatic niches","volume":"8","author":"Rafii","year":"2006","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib66","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/j.1460-2075.1984.tb01789.x","article-title":"Identity of P36k phosphorylated upon rous-sarcoma virus transformation with a protein purified from brush-borders - calcium-dependent binding to non-erythroid spectrin and f-actin","volume":"3","author":"Gerke","year":"1984","journal-title":"Embo J."},{"issue":"38","key":"10.1016\/j.biopha.2026.119358_bib67","doi-asserted-by":"crossref","first-page":"23930","DOI":"10.1074\/jbc.272.38.23930","article-title":"Basic helix-loop-helix protein sequences determining differential inhibition by calmodulin and S-100 proteins","volume":"272","author":"Onions","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"32","key":"10.1016\/j.biopha.2026.119358_bib68","doi-asserted-by":"crossref","first-page":"29186","DOI":"10.1074\/jbc.M505000200","article-title":"The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity","volume":"280","author":"Mueller","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"52","key":"10.1016\/j.biopha.2026.119358_bib69","doi-asserted-by":"crossref","first-page":"44845","DOI":"10.1074\/jbc.M111.225466","article-title":"Tumor-suppressive effects of psoriasin (S100A7) are mediated through the \u03b2-catenin\/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells","volume":"286","author":"Deol","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib70","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10549-013-2491-4","article-title":"Differential role of psoriasin (S100A7) in estrogen receptor \u03b1 positive and negative breast cancer cells occur through actin remodeling","volume":"138","author":"Sneh","year":"2013","journal-title":"Breast Cancer Res Treat."},{"issue":"6","key":"10.1016\/j.biopha.2026.119358_bib71","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2500\/aap.2006.27.2907","article-title":"Production of interferon gamma in asthmatic patients with small bacille Calmette-Guerin scars: a pilot study","volume":"27","author":"Oliveira","year":"2006","journal-title":"Allergy Asthma Proc."},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib72","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1134\/S1607672919030050","article-title":"Thapsigargin, inhibitor of sarco-endoplasmic Ca(2+)-ATPase, effectively suppresses the expression of s100a4 protein in human breast cancer cell line","volume":"486","author":"Kotnova","year":"2019","journal-title":"Dokl. Biochem Biophys."},{"issue":"Pt 6","key":"10.1016\/j.biopha.2026.119358_bib73","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1099\/ijs.0.64363-0","article-title":"Mesorhizobium albiziae sp. nov., a novel bacterium that nodulates Albizia kalkora in a subtropical region of China","volume":"57","author":"Wang","year":"2007","journal-title":"Int J. Syst. Evol. Microbiol"},{"key":"10.1016\/j.biopha.2026.119358_bib74","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12885-015-1059-6","article-title":"Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion","volume":"15","author":"Tanaka","year":"2015","journal-title":"BMC Cancer"},{"issue":"20","key":"10.1016\/j.biopha.2026.119358_bib75","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1080\/15384101.2016.1220460","article-title":"Discovery at the interface: Toward novel anti-proliferative agents targeting human estrogen receptor\/S100 interactions","volume":"15","author":"Lee","year":"2016","journal-title":"Cell Cycle"},{"issue":"7","key":"10.1016\/j.biopha.2026.119358_bib76","first-page":"2627","article-title":"Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer","volume":"9","author":"Emberley","year":"2003","journal-title":"Clin. Cancer Res"},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib77","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/(SICI)1097-0215(20000320)89:2<198::AID-IJC16>3.0.CO;2-L","article-title":"Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer","volume":"89","author":"Platt-Higgins","year":"2000","journal-title":"Int J. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2026.119358_bib78","first-page":"1595","article-title":"Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer","volume":"60","author":"Rudland","year":"2000","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib79","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1158\/0008-5472.CAN-05-2605","article-title":"Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib80","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s13277-010-0137-2","article-title":"The role of S100 genes in breast cancer progression","volume":"32","author":"McKiernan","year":"2011","journal-title":"Tumour Biol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119358_bib81","doi-asserted-by":"crossref","first-page":"e1067","DOI":"10.1016\/j.clbc.2018.03.013","article-title":"Presence of S100A8\/Gr1-Positive Myeloid-Derived Suppressor Cells in Primary Tumors and Visceral Organs Invaded by Breast Carcinoma Cells","volume":"18","author":"Tanriover","year":"2018","journal-title":"Clin. Breast Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib82","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11307-019-01370-1","article-title":"Target-Specific Imaging of Cathepsin and S100A8\/A9 Reflects Specific Features of Malignancy and Enables Estimation of Tumor Malignancy","volume":"22","author":"Helfen","year":"2020","journal-title":"Mol. Imaging Biol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119358_bib83","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.7150\/thno.17138","article-title":"Visualization of Tumor-Immune Interaction - Target-Specific Imaging of S100A8\/A9 Reveals Pre-Metastatic Niche Establishment","volume":"7","author":"Eisenblaetter","year":"2017","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib84","first-page":"433","article-title":"S100B expression in breast cancer as a predictive marker for cancer metastasis","volume":"52","author":"Yen","year":"2018","journal-title":"Int J. Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119358_bib85","first-page":"1301","article-title":"Ca2+-binding protein S100A11: a novel diagnostic marker for breast carcinoma","volume":"23","author":"Liu","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2026.119358_bib86","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/1471-2407-12-266","article-title":"Hornerin, an S100 family protein, is functional in breast cells and aberrantly expressed in breast cancer","volume":"12","author":"Fleming","year":"2012","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib87","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12929-014-0097-8","article-title":"Up-regulation of S100A16 expression promotes epithelial-mesenchymal transition via Notch1 pathway in breast cancer","volume":"21","author":"Zhou","year":"2014","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib88","first-page":"303","article-title":"New serum tumor markers S100, TFF3 and AIF-1 and their possible use in oncogynecology","volume":"84","author":"Mad\u011brka","year":"2019","journal-title":"Ceska Gynekol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.31","article-title":"S100A2 is a BRCA1\/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability","volume":"5","author":"Buckley","year":"2014","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.biopha.2026.119358_bib90","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1111\/cas.14659","article-title":"Upregulation of S100A10 in metastasized breast cancer stem cells","volume":"111","author":"Yanagi","year":"2020","journal-title":"Cancer Sci."},{"issue":"49","key":"10.1016\/j.biopha.2026.119358_bib91","doi-asserted-by":"crossref","first-page":"29064","DOI":"10.18632\/oncotarget.25561","article-title":"A multiomics analysis of S100 protein family in breast cancer","volume":"9","author":"Cancemi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119358_bib92","doi-asserted-by":"crossref","first-page":"39786","DOI":"10.1038\/srep39786","article-title":"Distinct prognostic values of S100 mRNA expression in breast cancer","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib93","first-page":"5285","article-title":"Protein S100-A8: A potential metastasis-associated protein for breast cancer determined via iTRAQ quantitative proteomic and clinicopathological analysis","volume":"15","author":"Zhong","year":"2018","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib95","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/(SICI)1097-0215(20000415)86:2<219::AID-IJC11>3.0.CO;2-7","article-title":"Localisation by in situ hybridisation of S100A4 (p9Ka) mRNA in primary human breast tumour specimens","volume":"86","author":"Nikitenko","year":"2000","journal-title":"Int J. Cancer"},{"issue":"7","key":"10.1016\/j.biopha.2026.119358_bib96","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/ijc.22850","article-title":"Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer","volume":"121","author":"Cabez\u00f3n","year":"2007","journal-title":"Int J. Cancer"},{"issue":"13","key":"10.1016\/j.biopha.2026.119358_bib97","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M113.534271","article-title":"12-O-tetradecanoylphorbol-13-acetate promotes breast cancer cell motility by increasing S100A14 level in a Kruppel-like transcription factor 4 (KLF4)-dependent manner","volume":"289","author":"He","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib98","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2174\/156800908784533445","article-title":"S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast","volume":"8","author":"Arai","year":"2008","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.biopha.2026.119358_bib99","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biopha.2015.10.029","article-title":"Diagnostic importance of S100A9 and S100A12 in breast cancer","volume":"76","author":"Gunaldi","year":"2015","journal-title":"Biomed. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2026.119358_bib100","first-page":"637","article-title":"Expression and clinical significance of calcium-binding protein S100A9 in breast cancer","volume":"28","author":"Du","year":"2012","journal-title":"Xi Bao Yu Fen. Zi Mian Yi Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib101","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s43046-020-00048-y","article-title":"S100A14 serum level and its correlation with prognostic factors in breast cancer","volume":"32","author":"Al-Ashkar","year":"2020","journal-title":"J. Egypt Natl. Canc Inst."},{"issue":"11","key":"10.1016\/j.biopha.2026.119358_bib102","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1054\/bjoc.2000.1488","article-title":"Expression of calcium-binding protein S100A2 in breast lesions","volume":"83","author":"Liu","year":"2000","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.biopha.2026.119358_bib103","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/ijc.28497","article-title":"Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma","volume":"134","author":"Parris","year":"2014","journal-title":"Int J. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00432-011-1062-5","article-title":"Calcium-binding protein S100P and cancer: mechanisms and clinical relevance","volume":"138","author":"Jiang","year":"2012","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119358_bib105","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1073\/pnas.89.6.2504","article-title":"Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment","volume":"89","author":"Lee","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib106","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1200\/JCO.2003.03.024","article-title":"Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma","volume":"21","author":"Gupta","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib107","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0143-4160(97)90063-4","article-title":"Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site specific hypermethylation","volume":"22","author":"Wicki","year":"1997","journal-title":"Cell Calcium"},{"key":"10.1016\/j.biopha.2026.119358_bib108","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1196\/annals.1282.070","article-title":"Relaxin downregulates the calcium binding protein S100A4 in MDA-MB-231 human breast cancer cells","volume":"1041","author":"Radestock","year":"2005","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119358_bib109","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/jrr\/rrab049","article-title":"Chk1 suppression leads to a reduction in the enhanced radiation-induced invasive capability on breast cancer cells","volume":"62","author":"Adachi","year":"2021","journal-title":"J. Radiat. Res"},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/omi.2012.0054","article-title":"Proteomic profiling and interactome analysis of ER-positive\/HER2\/neu negative invasive ductal carcinoma of the breast: towards proteomics biomarkers","volume":"17","author":"Korwar","year":"2013","journal-title":"OMICS"},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib111","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbrc.2012.09.057","article-title":"The histone demethylase LSD1 is required for estrogen-dependent S100A7 gene expression in human breast cancer cells","volume":"427","author":"Yu","year":"2012","journal-title":"Biochem Biophys. Res Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib112","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12916-017-0836-2","article-title":"S100\u03b2 as a serum marker in endocrine resistant breast cancer","volume":"15","author":"Charmsaz","year":"2017","journal-title":"BMC Med"},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib113","first-page":"359","article-title":"Nutritional support for wound healing","volume":"8","author":"MacKay","year":"2003","journal-title":"Alter. Med Rev."},{"issue":"6","key":"10.1016\/j.biopha.2026.119358_bib114","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-03-3070","article-title":"NY-ESO-1 Expression and Immunogenicity in Malignant and Benign Breast Tumors","volume":"64","author":"Sugita","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119358_bib115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1471-2407-7-205","article-title":"S100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells","volume":"7","author":"Petersson","year":"2007","journal-title":"BMC Cancer"},{"issue":"14","key":"10.1016\/j.biopha.2026.119358_bib116","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/onc.2009.488","article-title":"S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer","volume":"29","author":"West","year":"2010","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib117","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ijc.2910630225","article-title":"Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22","volume":"63","author":"Moog-Lutz","year":"1995","journal-title":"Int J. Cancer"},{"issue":"8","key":"10.1016\/j.biopha.2026.119358_bib118","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1074\/mcp.M700487-MCP200","article-title":"Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes","volume":"7","author":"Gon\u00e7alves","year":"2008","journal-title":"Mol. Cell Proteom."},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib119","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10549-016-4096-1","article-title":"Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer","volume":"162","author":"Egeland","year":"2017","journal-title":"Breast Cancer Res Treat."},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib120","first-page":"513","article-title":"Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients","volume":"28","author":"Maciejczyk","year":"2013","journal-title":"Histol. Histopathol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib121","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1074\/jbc.M113.469718","article-title":"S100A14, a member of the EF-hand calcium-binding proteins, is overexpressed in breast cancer and acts as a modulator of HER2 signaling","volume":"289","author":"Xu","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2026.119358_bib122","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/1878-0261.12493","article-title":"Biochemical pathways mediated by KLK6 protease in breast cancer","volume":"13","author":"Pampalakis","year":"2019","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.biopha.2026.119358_bib123","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s12885-016-2448-1","article-title":"Serum HER2 extra-cellular domain, S100\u00df and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients","volume":"16","author":"Darlix","year":"2016","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib124","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1158\/0008-5472.CAN-09-3713","article-title":"Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer [corrected]","volume":"70","author":"McIlroy","year":"2010","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib125","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10549-016-3776-1","article-title":"Plasma S100P level as a novel prognostic marker of metastatic breast cancer","volume":"157","author":"Peng","year":"2016","journal-title":"Breast Cancer Res Treat."},{"issue":"10","key":"10.1016\/j.biopha.2026.119358_bib126","doi-asserted-by":"crossref","first-page":"7014","DOI":"10.1002\/jcp.30364","article-title":"Cancer-associated fibroblasts induce an aggressive phenotypic shift in non-malignant breast epithelial cells via interleukin-8 and S100A8","volume":"236","author":"Lim","year":"2021","journal-title":"J. Cell Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib127","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10549-014-3122-4","article-title":"Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome","volume":"148","author":"Drews-Elger","year":"2014","journal-title":"Breast Cancer Res Treat."},{"issue":"11","key":"10.1016\/j.biopha.2026.119358_bib128","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/pin.12861","article-title":"Multiple functions of S100A10, an important cancer promoter","volume":"69","author":"Saiki","year":"2019","journal-title":"Pathol. Int"},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10549-017-4366-6","article-title":"Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome","volume":"166","author":"Miller","year":"2017","journal-title":"Breast Cancer Res Treat."},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2967\/jnumed.114.146688","article-title":"Optical in vivo imaging of the alarmin S100A9 in tumor lesions allows for estimation of the individual malignant potential by evaluation of tumor-host cell interaction","volume":"56","author":"Becker","year":"2015","journal-title":"J. Nucl. Med"},{"issue":"14","key":"10.1016\/j.biopha.2026.119358_bib131","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/s41388-018-0599-z","article-title":"S100A3 a partner protein regulating the stability\/activity of RAR\u03b1 and PML-RAR\u03b1 in cellular models of breast\/lung cancer and acute myeloid leukemia","volume":"38","author":"Gianni","year":"2019","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.biopha.2026.119358_bib132","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.cellsig.2014.06.007","article-title":"S100A4 negatively regulates \u03b2-catenin by inducing the Egr-1-PTEN-Akt-GSK3\u03b2 degradation pathway","volume":"26","author":"Yang","year":"2014","journal-title":"Cell Signal"},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib133","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/jcmm.14012","article-title":"Osterix promotes the migration and angiogenesis of breast cancer by upregulation of S100A4 expression","volume":"23","author":"Qu","year":"2019","journal-title":"J. Cell Mol. Med"},{"issue":"9","key":"10.1016\/j.biopha.2026.119358_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094720","article-title":"S100A4 Is Involved in Stimulatory Effects Elicited by the FGF2\/FGFR1 Signaling Pathway in Triple-Negative Breast Cancer (TNBC) Cells","volume":"22","author":"Santolla","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2026.119358_bib135","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/1878-0261.12319","article-title":"Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4","volume":"12","author":"Prasmickaite","year":"2018","journal-title":"Mol. Oncol."},{"issue":"36","key":"10.1016\/j.biopha.2026.119358_bib136","doi-asserted-by":"crossref","first-page":"30228","DOI":"10.1074\/jbc.M112.343947","article-title":"The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells","volume":"287","author":"Liu","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.biopha.2026.119358_bib137","first-page":"3844","article-title":"Blocking TGF-\u03b2 inhibits breast cancer cell invasiveness via ERK\/S100A4 signal","volume":"18","author":"Wang","year":"2014","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib138","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13058-017-0863-0","article-title":"Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment","volume":"19","author":"Sakurai","year":"2017","journal-title":"Breast Cancer Res"},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001741","article-title":"S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation","volume":"3","author":"Paruchuri","year":"2008","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2026.119358_bib140","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1158\/0008-5472.CAN-14-2161","article-title":"RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment","volume":"75","author":"Nasser","year":"2015","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib141","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1158\/0008-5472.CAN-11-0669","article-title":"S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways","volume":"72","author":"Nasser","year":"2012","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib142","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/bcr816","article-title":"S100A7 and the progression of breast cancer","volume":"6","author":"Emberley","year":"2004","journal-title":"Breast Cancer Res"},{"issue":"13","key":"10.1016\/j.biopha.2026.119358_bib143","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1158\/0008-5472.CAN-04-3927","article-title":"The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer","volume":"65","author":"Emberley","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2026.119358_bib144","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12943-014-0275-z","article-title":"miR-29b defines the pro-\/anti-proliferative effects of S100A7 in breast cancer","volume":"14","author":"Zhao","year":"2015","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10549-011-1920-5","article-title":"Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation","volume":"134","author":"Shubbar","year":"2012","journal-title":"Breast Cancer Res Treat."},{"issue":"8","key":"10.1016\/j.biopha.2026.119358_bib146","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/bjc.2015.346","article-title":"S100A9 expressed in ER(-)PgR(-) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival","volume":"113","author":"Bergenfelz","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.biopha.2026.119358_bib147","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/nm.4405","article-title":"Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence","volume":"23","author":"Goh","year":"2017","journal-title":"Nat. Med"},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib148","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10549-013-2737-1","article-title":"RAGE-binding S100A8\/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition","volume":"142","author":"Yin","year":"2013","journal-title":"Breast Cancer Res Treat."},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib149","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00795-019-00236-3","article-title":"Membranous overexpression of S100A10 is associated with a high-grade cellular status of breast carcinoma","volume":"53","author":"Arai","year":"2020","journal-title":"Med Mol. Morphol."},{"issue":"19","key":"10.1016\/j.biopha.2026.119358_bib150","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1016\/j.febslet.2013.08.012","article-title":"Protein interactions between surface annexin A2 and S100A10 mediate adhesion of breast cancer cells to microvascular endothelial cells","volume":"587","author":"Myrvang","year":"2013","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib151","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2559.2005.02097.x","article-title":"Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers","volume":"46","author":"Cross","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.biopha.2026.119358_bib152","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.566302","article-title":"Calcium-Binding Protein S100P Promotes Tumor Progression but Enhances Chemosensitivity in Breast Cancer","volume":"10","author":"Cong","year":"2020","journal-title":"Front Oncol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib153","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4048\/jbc.2016.19.2.142","article-title":"Hornerin Is Involved in Breast Cancer Progression","volume":"19","author":"Choi","year":"2016","journal-title":"J. Breast Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib154","article-title":"The role of TG2 in regulating S100A4-mediated mammary tumour cell migration","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib155","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1042\/BJ20090990","article-title":"Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-beta-mediated cancer cell invasiveness","volume":"426","author":"Matsuura","year":"2010","journal-title":"Biochem J."},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib156","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010374","article-title":"Metastasis-inducing S100A4 and RANTES cooperate in promoting tumor progression in mice","volume":"5","author":"Forst","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biopha.2026.119358_bib157","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/0959-8049(94)00320-5","article-title":"The S-100-related calcium-binding protein, p9Ka, and metastasis in rodent and human mammary cells","volume":"30A","author":"Barraclough","year":"1994","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib158","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1158\/0008-5472.CAN-16-1802","article-title":"S100A4 Elevation Empowers Expression of Metastasis Effector Molecules in Human Breast Cancer","volume":"77","author":"Ismail","year":"2017","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.biopha.2026.119358_bib159","first-page":"1631","article-title":"Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours","volume":"13","author":"Davies","year":"1996","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.biopha.2026.119358_bib160","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1593\/neo.121554","article-title":"Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion","volume":"14","author":"Klingelh\u00f6fer","year":"2012","journal-title":"Neoplasia"},{"issue":"15","key":"10.1016\/j.biopha.2026.119358_bib161","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1091\/mbc.e09-07-0609","article-title":"S100A4 regulates macrophage chemotaxis","volume":"21","author":"Li","year":"2010","journal-title":"Mol. Biol. Cell"},{"issue":"Pt 12","key":"10.1016\/j.biopha.2026.119358_bib162","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1242\/jcs.03460","article-title":"CTGF enhances the motility of breast cancer cells via an integrin-alphavbeta3-ERK1\/2-dependent S100A4-upregulated pathway","volume":"120","author":"Chen","year":"2007","journal-title":"J. Cell Sci."},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib163","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/onc.2013.568","article-title":"A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4","volume":"34","author":"Hansen","year":"2015","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib164","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.bjc.6601483","article-title":"S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis","volume":"90","author":"Jenkinson","year":"2004","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2026.119358_bib165","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.3892\/ijo.2016.3491","article-title":"Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH","volume":"48","author":"Gr\u00fcndker","year":"2016","journal-title":"Int J. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib166","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2613.2003.00350.x","article-title":"Examination of tumour histopathology and gene expression in a neu\/S100A4 transgenic model of metastatic breast cancer","volume":"84","author":"Simpson","year":"2003","journal-title":"Int J. Exp. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib167","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1074\/jbc.R500017200","article-title":"S100A4, a mediator of metastasis","volume":"281","author":"Garrett","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"38","key":"10.1016\/j.biopha.2026.119358_bib168","doi-asserted-by":"crossref","first-page":"16002","DOI":"10.1073\/pnas.1109493108","article-title":"VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization","volume":"108","author":"O'Connell","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.biopha.2026.119358_bib169","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0002-9440(10)65524-1","article-title":"Psoriasin (S100A7) expression and invasive breast cancer","volume":"155","author":"Al-Haddad","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib170","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1134\/S1607672919020030","article-title":"The Expression Level of S100A4 Protein Affects the Migration Activity of Breast Cancer Cells","volume":"485","author":"Dukhanina","year":"2019","journal-title":"Dokl. Biochem Biophys."},{"issue":"14","key":"10.1016\/j.biopha.2026.119358_bib171","doi-asserted-by":"crossref","first-page":"23564","DOI":"10.18632\/oncotarget.15797","article-title":"HRD1 sensitizes breast cancer cells to Tamoxifen by promoting S100A8 degradation","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib172","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","article-title":"A CXCL1 paracrine network links cancer chemoresistance and metastasis","volume":"150","author":"Acharyya","year":"2012","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biopha.2026.119358_bib173","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.3892\/or.2015.4307","article-title":"Benzyl butyl phthalate increases the chemoresistance to doxorubicin\/cyclophosphamide by increasing breast cancer-associated dendritic cell-derived CXCL1\/GRO\u03b1 and S100A8\/A9","volume":"34","author":"Hsu","year":"2015","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib174","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1021\/pr2008187","article-title":"Proteomic approach reveals FKBP4 and S100A9 as potential prediction markers of therapeutic response to neoadjuvant chemotherapy in patients with breast cancer","volume":"11","author":"Yang","year":"2012","journal-title":"J. Proteome Res"},{"issue":"9","key":"10.1016\/j.biopha.2026.119358_bib175","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1172\/JCI138577","article-title":"Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness","volume":"130","author":"Lu","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.biopha.2026.119358_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118677","article-title":"Role of S100 proteins in health and disease","volume":"1867","author":"Gonzalez","year":"2020","journal-title":"Biochim Biophys. Acta Mol. Cell Res"},{"issue":"6","key":"10.1016\/j.biopha.2026.119358_bib177","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8060059","article-title":"S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis Restriction","volume":"8","author":"Dahlmann","year":"2016","journal-title":"Cancers (Basel)"},{"issue":"18","key":"10.1016\/j.biopha.2026.119358_bib178","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1091\/mbc.e10-09-0739","article-title":"S100A4-induced cell motility and metastasis is restricted by the Wnt\/\u03b2-catenin pathway inhibitor calcimycin in colon cancer cells","volume":"22","author":"Sack","year":"2011","journal-title":"Mol. Biol. Cell"},{"issue":"13","key":"10.1016\/j.biopha.2026.119358_bib179","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/jnci\/djr190","article-title":"Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer","volume":"103","author":"Sack","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib180","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12885-018-4197-9","article-title":"Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial","volume":"18","author":"Burock","year":"2018","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib181","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1021\/bi7021624","article-title":"A biosensor of S100A4 metastasis factor activation: inhibitor screening and cellular activation dynamics","volume":"47","author":"Garrett","year":"2008","journal-title":"Biochemistry"},{"issue":"19","key":"10.1016\/j.biopha.2026.119358_bib182","doi-asserted-by":"crossref","first-page":"8605","DOI":"10.1073\/pnas.0913660107","article-title":"Phenothiazines inhibit S100A4 function by inducing protein oligomerization","volume":"107","author":"Malashkevich","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119358_bib183","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.intimp.2018.12.008","article-title":"Effects of Platycodin D on S100A8\/A9-induced inflammatory response in murine mammary carcinoma 4T1 cells","volume":"67","author":"Ye","year":"2019","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib184","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00280-013-2321-8","article-title":"Mechanisms of action of tasquinimod on the tumour microenvironment","volume":"73","author":"Raymond","year":"2014","journal-title":"Cancer Chemother. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib185","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1158\/2326-6066.CIR-14-0036","article-title":"Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models","volume":"3","author":"Shen","year":"2015","journal-title":"Cancer Immunol. Res"},{"issue":"10","key":"10.1016\/j.biopha.2026.119358_bib186","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1072672","article-title":"Tasquinimod targets suppressive myeloid cells in the tumor microenvironment","volume":"8","author":"Shen","year":"2019","journal-title":"Oncoimmunology"},{"issue":"22","key":"10.1016\/j.biopha.2026.119358_bib187","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2016.66.9697","article-title":"Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer","volume":"34","author":"Sternberg","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119358_bib188","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/cmdc.201200107","article-title":"Three-dimensional pharmacophore design and biochemical screening identifies substituted 1,2,4-triazoles as inhibitors of the annexin\u2005A2-S100A10 protein interaction","volume":"7","author":"Reddy","year":"2012","journal-title":"ChemMedChem"},{"issue":"19","key":"10.1016\/j.biopha.2026.119358_bib189","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1016\/j.bmc.2014.07.043","article-title":"Design, synthesis and SAR exploration of tri-substituted 1,2,4-triazoles as inhibitors of the annexin A2-S100A10 protein interaction","volume":"22","author":"Reddy","year":"2014","journal-title":"Bioorg. Med Chem."},{"issue":"7","key":"10.1016\/j.biopha.2026.119358_bib190","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1021\/jm101212e","article-title":"Design, synthesis, and structure-activity relationship exploration of 1-substituted 4-aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-one analogues as inhibitors of the annexin A2-S100A10 protein interaction","volume":"54","author":"Reddy","year":"2011","journal-title":"J. Med Chem."},{"issue":"21","key":"10.1016\/j.biopha.2026.119358_bib191","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1021\/jm0497038","article-title":"Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction","volume":"47","author":"Markowitz","year":"2004","journal-title":"J. Med Chem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib192","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/CAD.0b013e3283340cee","article-title":"The effect of pentamidine on melanoma ex vivo","volume":"21","author":"Smith","year":"2010","journal-title":"Anticancer Drugs"},{"issue":"5","key":"10.1016\/j.biopha.2026.119358_bib193","doi-asserted-by":"crossref","DOI":"10.3390\/biom11050634","article-title":"S100P Interacts with p53 while Pentamidine Inhibits This Interaction","volume":"11","author":"Katte","year":"2021","journal-title":"Biomolecules"},{"issue":"15","key":"10.1016\/j.biopha.2026.119358_bib194","article-title":"Treatment of melanoma with wild-type p53 (wtp53) and detectable S100B using pentamidine: A phase II trial with correlative biomarker endpoints","volume":"28","author":"Mehnert","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"24","key":"10.1016\/j.biopha.2026.119358_bib195","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/jnci\/djj498","article-title":"Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models","volume":"98","author":"Arumugam","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"issue":"Pt 3","key":"10.1016\/j.biopha.2026.119358_bib196","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1042\/bj3380583","article-title":"Three distinct anti-allergic drugs, amlexanox, cromolyn and tranilast, bind to S100A12 and S100A13 of the S100 protein family","volume":"338","author":"Shishibori","year":"1999","journal-title":"Biochem J."},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib197","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1006\/bbrc.2002.6761","article-title":"Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: identification of putative drug binding sites on S100A1 protein","volume":"292","author":"Okada","year":"2002","journal-title":"Biochem Biophys. Res Commun."},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib198","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbrc.2014.10.048","article-title":"Interaction between S100P and the anti-allergy drug cromolyn","volume":"454","author":"Penumutchu","year":"2014","journal-title":"Biochem Biophys. Res Commun."},{"issue":"5","key":"10.1016\/j.biopha.2026.119358_bib199","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/1535-7163.MCT-12-0771","article-title":"Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy","volume":"12","author":"Arumugam","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"7","key":"10.1016\/j.biopha.2026.119358_bib200","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1074\/jbc.M806051200","article-title":"Up-regulation of S100P expression by non-steroidal anti-inflammatory drugs and its role in anti-tumorigenic effects","volume":"284","author":"Namba","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2026.119358_bib201","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12885-015-1034-2","article-title":"S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance","volume":"15","author":"Grum-Schwensen","year":"2015","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.biopha.2026.119358_bib202","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072480","article-title":"Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody","volume":"8","author":"Hern\u00e1ndez","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib203","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3892\/ijo.2021.5173","article-title":"Inhibition of the invasion and metastasis of mammary carcinoma cells by NBD peptide targeting S100A4 via the suppression of the Sp1\/MMP\u201114 axis","volume":"58","author":"Takenaga","year":"2021","journal-title":"Int J. Oncol."},{"issue":"49","key":"10.1016\/j.biopha.2026.119358_bib204","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1038\/onc.2017.283","article-title":"S100A7: from mechanism to cancer therapy","volume":"36","author":"Padilla","year":"2017","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib205","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ijc.31982","article-title":"Newly developed anti-S100A8\/A9 monoclonal antibody efficiently prevents lung tropic cancer metastasis","volume":"145","author":"Kinoshita","year":"2019","journal-title":"Int J. Cancer"},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib206","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2014.7","article-title":"S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer","volume":"3","author":"Dakhel","year":"2014","journal-title":"Oncogenesis"},{"issue":"15","key":"10.1016\/j.biopha.2026.119358_bib207","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1158\/1078-0432.CCR-05-0092","article-title":"S100P promotes pancreatic cancer growth, survival, and invasion","volume":"11","author":"Arumugam","year":"2005","journal-title":"Clin. Cancer Res"},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib208","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00726-010-0496-4","article-title":"S100P: a novel therapeutic target for cancer","volume":"41","author":"Arumugam","year":"2011","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib209","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.canlet.2016.08.011","article-title":"miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4","volume":"381","author":"Dou","year":"2016","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.biopha.2026.119358_bib210","first-page":"2209","article-title":"Expression of miR-149-3p inhibits proliferation, migration, and invasion of bladder cancer by targeting S100A4","volume":"7","author":"Yang","year":"2017","journal-title":"Am. J. Cancer Res"},{"issue":"8","key":"10.1016\/j.biopha.2026.119358_bib211","first-page":"4634","article-title":"S100A6\/miR193a regulates the proliferation, invasion, migration and angiogenesis of lung cancer cells through the P53 acetylation","volume":"11","author":"Li","year":"2019","journal-title":"Am. J. Transl. Res"},{"issue":"1","key":"10.1016\/j.biopha.2026.119358_bib212","first-page":"386","article-title":"MicroRNA-26b-5p regulates cell proliferation, invasion and metastasis in human intrahepatic cholangiocarcinoma by targeting S100A7","volume":"15","author":"Fan","year":"2018","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2026.119358_bib213","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3892\/or.2011.1571","article-title":"miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein","volume":"27","author":"Guo","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2026.119358_bib214","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.12659\/MSM.899179","article-title":"Targeted Silencing of S100A8 Gene by miR-24 to Increase Chemotherapy Sensitivity of Endometrial Carcinoma Cells to Paclitaxel","volume":"22","author":"Lang","year":"2016","journal-title":"Med Sci. Monit."},{"issue":"3","key":"10.1016\/j.biopha.2026.119358_bib215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3727\/096504019X15753718797664","article-title":"MicroRNA-6884-5p Regulates the Proliferation, Invasion, and EMT of Gastric Cancer Cells by Directly Targeting S100A16","volume":"28","author":"Lv","year":"2020","journal-title":"Oncol. Res"},{"issue":"2","key":"10.1016\/j.biopha.2026.119358_bib216","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1593\/neo.101172","article-title":"Intervening in \u03b2-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis","volume":"13","author":"Stein","year":"2011","journal-title":"Neoplasia"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226003914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226003914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:29:06Z","timestamp":1779244146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226003914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":215,"alternative-id":["S0753332226003914"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119358","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic insights and clinical implications of the S100 protein family in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119358"}}